Lu Chao, Chen Jie, Gao Feng, Pan Donggang, Wang Xian, Zhang Shinian
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, Jiangsu Province, China.
Zhenjiang First People's Hospital, Zhenjiang, Jiangsu, 212002, China.
J Orthop Surg Res. 2025 Jul 28;20(1):716. doi: 10.1186/s13018-025-06128-w.
Cervical vertigo (CV) is highly prevalent clinically, yet effective treatments are limited. Manual therapy, an important alternative, shows potential in the treatment of patients with CV. Unfortunately, the quality of current relevant research evidence is poor, and most manual therapies only focus on the local cervical spine. There are few studies on whole-spine synergistic manual therapy. Therefore, we aimed to conduct a randomized controlled trial (RCT) to explore the short-term efficacy of synergistic manual therapy for patients with. CV.
The clinical study is RCT. A total of 138 patients will be randomly assigned to the synergistic manual therapy (SM) group, cervical manual therapy (CM) group, or waiting list (WL) group in a 1:1:1 ratio for 2 weeks with a 3-month follow-up. The primary outcome will be the mean change of vertigo intensity measured by the Dizziness Handicap Inventory (DHI). The secondary outcomes will include the vertebrobasilar artery blood flow velocity, the Essex-Symonds Cervical Vertebral Index Scale (ESCV) score, 36-item Short-Form Health Survey (SF-36) score, and adverse events (AEs).
This randomized trial will be the first rigorous study designed to assess the short-term efficacy of SM therapy in comparison with local CM therapy or no treatment among patients with CV. The finding of this study will provide an objective clinical basis for the use of SM therapy for patients with CV in the future.
International Traditional Medicine Clinical Trials, ITMCTR2025000184. Registered on 25 January 2025.
颈性眩晕(CV)在临床上极为常见,但有效的治疗方法有限。手法治疗作为一种重要的替代疗法,在CV患者的治疗中显示出潜力。遗憾的是,当前相关研究证据质量较差,且大多数手法治疗仅关注颈椎局部。关于全脊柱协同手法治疗的研究较少。因此,我们旨在进行一项随机对照试验(RCT),以探讨协同手法治疗对CV患者的短期疗效。
本临床研究为RCT。总共138例患者将按1:1:1的比例随机分配至协同手法治疗(SM)组、颈椎手法治疗(CM)组或等待列表(WL)组,为期2周,并进行3个月的随访。主要结局将是通过头晕残障量表(DHI)测量的眩晕强度的平均变化。次要结局将包括椎基底动脉血流速度、埃塞克斯 - 西蒙兹颈椎指数量表(ESCV)评分、36项简明健康调查(SF - 36)评分以及不良事件(AE)。
这项随机试验将是第一项严谨的研究,旨在评估SM疗法与局部CM疗法或不治疗相比,在CV患者中的短期疗效。本研究的结果将为未来CV患者使用SM疗法提供客观的临床依据。
国际传统医学临床试验,ITMCTR2025000184。于2025年1月25日注册。